Enzyme-linked immunosorbent assay and polymerase chain reaction performance using Mexican and Guatemalan discrete typing unit I strains of Trypanosoma cruzi.

Thirteen Trypanosoma cruzi isolates from different geographic regions of Mexico and Guatemala belonging to discrete typing unit (DTU) I and a reference CL-Brener (DTU VI) strain were used to perform enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR). A panel of 57 Mexican serum samples of patients with chronic chagasic cardiopathy and asymptomatic infected subjects (blood bank donors) were used in this study. DNA from the above 14 T. cruzi strains were extracted and analyzed by PCR using different sets of primers designed from minicircle and satellite T. cruzi DNA. The chronic chagasic cardiopathy serum samples were easily recognized with ELISA regardless of the source of antigenic extract used, even with the CL-Brener TcVI, but positive serum samples from blood bank donors in some cases were not recognized by some Mexican antigenic extracts. On the other hand, PCR showed an excellent performance despite the set of primers used, since all Mexican and Guatemalan T. cruzi strains were correctly amplified. In general terms, Mexican, Guatemalan, and CL-Brener T. cruzi strains are equally good sources of antigen when using the ELISA test to detect Mexican serum samples. However, there are some strains with poor performance. The DTU I strains are easily detected using either kinetoplast or satellite DNA target designed from DTU VI strains.

[1]  K. Maemura,et al.  Lineage Analysis of Circulating Trypanosoma cruzi Parasites and Their Association with Clinical Forms of Chagas Disease in Bolivia , 2010, PLoS neglected tropical diseases.

[2]  A. Romanha,et al.  A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. , 2009, Memorias do Instituto Oswaldo Cruz.

[3]  C. Morillo,et al.  Evaluation of Adult Chronic Chagas' Heart Disease Diagnosis by Molecular and Serological Methods , 2009, Journal of Clinical Microbiology.

[4]  C. Ponce,et al.  Performance levels of four Latin American laboratories for the serodiagnosis of Chagas disease in Mexican sera samples. , 2009, Memorias do Instituto Oswaldo Cruz.

[5]  C. Britto.  Usefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: value and limitations. , 2009, Memorias do Instituto Oswaldo Cruz.

[6]  A. Luquetti,et al.  Diagnosis of Chagas disease: what has been achieved? What remains to be done with regard to diagnosis and follow up studies? , 2009, Memorias do Instituto Oswaldo Cruz.

[7]  M. S. Belluzo,et al.  Comparison of Recombinant Trypanosoma cruzi Peptide Mixtures versus Multiepitope Chimeric Proteins as Sensitizing Antigens for Immunodiagnosis , 2009, Clinical and Vaccine Immunology.

[8]  M. Shikanai-Yasuda,et al.  Inconclusive results in conventional serological screening for Chagas’ disease in blood banks: evaluation of cellular and humoral response , 2008, Tropical medicine & international health : TM & IH.

[9]  D. B. Weatherly,et al.  High Throughput Selection of Effective Serodiagnostics for Trypanosoma cruzi infection , 2008, PLoS neglected tropical diseases.

[10]  E. Peresi,et al.  Definition of a diagnostic routine in individuals with inconclusive serology for Chagas disease. , 2007, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[11]  V. Monteón,et al.  Trypanosoma cruzi isolates from Mexican and Guatemalan acute and chronic chagasic cardiopathy patients belong to Trypanosoma cruzi I. , 2005, Memorias do Instituto Oswaldo Cruz.

[12]  S. D. Pena,et al.  Trypanosoma cruzi: genetic structure of populations and relevance of genetic variability to the pathogenesis of chagas disease. , 2004, Memórias do Instituto Oswaldo Cruz.

[13]  J. F. da Silveira,et al.  Serodiagnosis of Chronic and Acute Chagas' Disease with Trypanosoma cruzi Recombinant Proteins: Results of a Collaborative Study in Six Latin American Countries , 2004, Journal of Clinical Microbiology.

[14]  J. Esfandiari,et al.  Chagas' disease diagnosis: a multicentric evaluation of Chagas Stat-Pak, a rapid immunochromatographic assay with recombinant proteins of Trypanosoma cruzi. , 2003, Diagnostic microbiology and infectious disease.

[15]  M. Svoboda,et al.  Comparison of polymerase chain reaction methods for reliable and easy detection of congenital Trypanosoma cruzi infection. , 2003, The American journal of tropical medicine and hygiene.

[16]  M. Levin,et al.  An improved serodiagnostic test for Chagas' disease employing a mixture of Trypanosoma cruzi recombinant antigens , 2003, Transfusion.

[17]  F. Guhl,et al.  Molecular characterization and diagnosis of trypanosoma cruzi and T. rangeli. , 2002, Archives of medical research.

[18]  J. Carrero,et al.  How protozoan parasites evade the immune response. , 2002, Trends in parasitology.

[19]  J. Ramsey,et al.  Predominance of Trypanosoma cruzi Lineage I in Mexico , 2002, Journal of Clinical Microbiology.

[20]  B. Stolf,et al.  The evolution of two Trypanosoma cruzi subgroups inferred from rRNA genes can be correlated with the interchange of American mammalian faunas in the Cenozoic and has implications to pathogenicity and host specificity. , 1999, Molecular and biochemical parasitology.

[21]  J. F. da Silveira,et al.  Evaluation of Recombinant Antigens for Serodiagnosis of Chagas’ Disease in South and Central America , 1999, Journal of Clinical Microbiology.

[22]  J. Coura,et al.  Evaluation of Three Commercial Enzyme-Linked Immunosorbent Assays for Diagnosis of Chagas’ Disease , 1998, Journal of Clinical Microbiology.

[23]  O. Fernandes,et al.  DNA markers define two major phylogenetic lineages of Trypanosoma cruzi. , 1996, Molecular and biochemical parasitology.

[24]  P. Wincker,et al.  Comparison of the polymerase chain reaction with two classical parasitological methods for the diagnosis of Chagas disease in an endemic region of north-eastern Brazil. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[25]  C. Garcia,et al.  Chronic chagasic cardiopathy with parasitemic state (preliminary report). , 1996 .

[26]  Carlos M. Morel,et al.  Polymerase chain reaction detection of Trypanosoma cruzi in human blood samples as a tool for diagnosis and treatment evaluation , 1995, Parasitology.

[27]  J. Donelson,et al.  Detection of Trypanosoma cruzi by DNA amplification using the polymerase chain reaction , 1989, Journal of clinical microbiology.

[28]  W. Degrave,et al.  Peculiar sequence organization of kinetoplast DNA minicircles from Trypanosoma cruzi. , 1988, Molecular and biochemical parasitology.